Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lachesis is a homeopathic medicinal product derived from the venom of the South American bushmaster snake, *Lachesis muta*. It is a prominent remedy in the homeopathic materia medica, traditionally indicated for conditions characterized by congestion and inflammation, such as menopausal hot flashes, pharyngitis (particularly when symptoms are more severe on the left side), and various circulatory disorders. The manufacturing process follows the standards of the Homeopathic Pharmacopoeia of the United States (HPUS), involving extreme serial dilution and succussion (potentization). While the raw venom contains complex bioactive proteins, including serine proteases and bradykinin-potentiating peptides that affect blood pressure and the coagulation cascade, the finished homeopathic product typically reaches potencies (such as 30C or 200C) where no molecules of the original venom remain. Consequently, it lacks a recognized molecular mechanism of action in conventional pharmacology and is categorized as a homeopathic drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lachesis muta.